Altogether, the evidence obtained from the different analyses performed led us to focus on MX1, since: (1) it showed a significant over-expression under HO-1 induction; (2) it was under-expressed in PCa vs. normal prostate; and (3) its low expression was associated with a significant decrease in RFS for PCa patients. The gene discussed is HMOX1; the disease is posterior cortical atrophy.